Gastric Ulcers Epidemiology Forecast 2025-2034

Gastric ulcers are a type of peptic ulcer disease, which affects 5 to 10% of people over their lifetime. The risk of developing gastric ulcers increases with age and long-term NSAID use. Smoking also doubles the likelihood of developing gastric ulcers compared to non-smokers.

Gastric Ulcers Epidemiology Forecast Report Coverage

The “Gastric Ulcers Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of gastric ulcers. It projects the future incidence and prevalence rates of gastric ulcers across various populations. The study covers age, gender, and type as major determinants of the gastric ulcers-affected population. The report highlights patterns in the prevalence of gastric ulcers over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of gastric ulcers in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Gastric Ulcers Disease Overview

Gastric ulcers, a type of peptic ulcer disease, are open sores that develop on the lining of the stomach. They occur when the stomach's protective mucus lining is damaged, which allows the stomach acids to erode the underlying tissue. Gastric ulcers can be caused by helicobacter pylori infection, chronic use of NSAIDs, excessive alcohol consumption, smoking, and stress, among others. Burning or gnawing pain in the stomach area, often between meals or at night, is a common symptom.

Gastric Ulcers: Treatment Overview

Proton pump inhibitors (PPIs), such as omeprazole, esomeprazole, and lansoprazole, are the most common treatment for gastric ulcers. PPIs reduce stomach acid production which helps in healing the ulcer. H2-receptor antagonist drugs (ranitidine and famotidine) also reduce acid production in the stomach. If the ulcer is caused by Helicobacter pylori (H. pylori) infection, antibiotics such as amoxicillin, clarithromycin, or metronidazole are prescribed to the patient.

Epidemiology

The gastric ulcers epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for gastric ulcers by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for gastric ulcers and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Gastric ulcers are a type of peptic ulcer disease, which affects 5% to 10% of patients over their lifetime. This number is likely to be an underestimation since some people may not show symptoms.
• Research shows that smokers are twice as likely to develop gastric ulcers compared to non-smokers. Additionally, about 25% of long-term NSAID users are estimated to develop gastric ulcers.
• H. pylori infection causes 70%-90% of gastric ulcers. It is also reported that the risk of H. pylori infection and peptic ulcer disease increases with age.
• Peptic ulcer disease affects approximately 11%-14% of men and 8%-11% of women during their lifetime.

Country-wise Gastric Ulcers Epidemiology

The gastric ulcers epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of gastric ulcers varies between countries owing to differences in dietary habits, healthcare access, prevalence of Helicobacter pylori infection, use of nonsteroidal anti-inflammatory drugs (NSAIDs), smoking rates, and genetic factors. In the United States, approximately 1% to 6% of the population has peptic ulcers.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of gastric ulcers based on several factors.
• Gastric Ulcers Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of gastric ulcers are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of gastric ulcers epidemiology in the 8 major markets?
• What will be the total number of patients with gastric ulcers across the 8 major markets during the forecast period?
• What was the country-wise prevalence of gastric ulcers in the 8 major markets in the historical period?
• Which country will have the highest number of gastric ulcers patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of gastric ulcers during the forecast period of 2025-2034?
• What are the currently available treatments for gastric ulcers?
• What are the disease risks, signs, symptoms, and unmet needs of gastric ulcers?

This product will be delivered within 3-5 business days.